Smoking and Obesity Interact to Adversely Affect Disease Progression and Cognitive Performance in Multiple Sclerosis
European Journal of Neurology · 2025
DOI: 10.1111/ene.70058 ↗At a glance
Journal article in European Journal of Neurology, 2025. Written by Johansson Eva and 3 co-authors. Institution: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Major MEDLINE topics: Disease Progression, Multiple Sclerosis, Obesity, Smoking. Cited 16 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Forskningsrådet om Hälsa, Arbetsliv och Välfärd, Vetenskapsrådet, Medicinska Forskningsrådet.
Abstract (original language)
Background
Smoking and obesity interact to exacerbate the risk of hypertension, diabetes, and cardiovascular disease, but their potential synergistic effects on outcomes in multiple sclerosis (MS) have not been well studied. We aimed to study whether smoking and obesity interact to affect disease progression and cognitive function in patients with MS.
Methods
Incident cases from the population‐based case–control study Epidemiological Investigation of MS (EIMS) were categorized by smoking and obesity status at diagnosis and followed up to 15 years postdiagnosis through the Swedish MS registry ( n = 3336). Cox regression was used to analyze outcomes, including clinical disease worsening (CDW), progression to Expanded Disability Status Scale (EDSS) levels 3 and 4, physical worsening as measured by a 7.5‐point increase in the MS Impact Scale (MSIS) physical score, and cognitive decline, defined as an 8‐point or greater reduction on the Symbol Digit Modalities Test (SDMT). Interaction effects on the additive scale were assessed by combining dichotomous variables for smoking (nonsmoker = 0, smoker = 1) and obesity (nonobese = 0, obese = 1), yielding four categories: 0/0 (reference category), 0/1, 1/0, and 1/1.
Results
Additive interactions between smoking and obesity were identified for CDW (attributable proportion due to interaction [AP] 0.18, 95% CI 0.03–0.30), progression to EDSS 4 (AP 0.18, 95% CI 0.08–0.26), MSIS‐Physical score worsening (AP 0.32, 95% CI 0.21–0.42), and cognitive decline (AP 0.27, 95% CI 0.19–0.35).
Conclusions
Smoking and obesity appear to synergistically worsen MS progression and cognitive functioning, with the observed additive interactions across most outcomes suggesting that these factors partly share common biological pathways contributing to disease progression.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Centre for Occupational and Environmental Medicine, Region Stockholm, Stockholm, Sweden.
ORCID profiles: Anna Karin Hedström
Funding
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
- Vetenskapsrådet
- Medicinska Forskningsrådet
- Swedish Brain Foundation
- Swedish Foundation for MS Research
- Margaretha af Ugglas Foundation
- Neuroförbundet
Cite
APA
Eva, J., Olsson, T., Alfredsson, L., & Hedström, A. K. (2025). Smoking and Obesity Interact to Adversely Affect Disease Progression and Cognitive Performance in Multiple Sclerosis. European Journal of Neurology. https://doi.org/10.1111/ene.70058
Vancouver
Eva J, Olsson T, Alfredsson L, Hedström AK. Smoking and Obesity Interact to Adversely Affect Disease Progression and Cognitive Performance in Multiple Sclerosis. European Journal of Neurology. 2025. doi:10.1111/ene.70058
BibTeX
@article{Eva2025,
author = {Eva, Johansson and Olsson, Tomas and Alfredsson, Lars and Hedström, Anna Karin},
title = {Smoking and Obesity Interact to Adversely Affect Disease Progression and Cognitive Performance in Multiple Sclerosis},
journal = {European Journal of Neurology},
year = {2025},
doi = {10.1111/ene.70058}
}
EUVIMED